What does 'purity' mean when it's printed on a peptide vial's label?

When printed on a research peptide vial, 'purity' typically refers to relative chromatographic purity determined by HPLC. It indicates the percentage of detectable, light-absorbing material that eluted at the expected retention time relative to all detected peaks. It does not mean the vial contains 100% active compound by weight, as non-absorbing components like moisture, counterions, and buffer salts are not accounted for in standard HPLC area percentages.

What is HPLC actually measuring when it reports a purity percentage?

HPLC measures the relative optical absorbance (commonly at 214 nm or 220 nm) of compounds as they separate through a stationary column over time. The purity percentage is calculated by dividing the area under the primary compound's peak by the sum of all integrated peak areas on the chromatogram.

How is mass spectrometry different from HPLC, and why do labs often run both?

HPLC separates compounds by their chemical affinity and retention time on a column, whereas mass spectrometry measures the exact mass-to-charge ratio of ionized molecules to determine their molecular weight. Running both (LC-MS) allows a laboratory to separate impurities and verify that the target peak matches the precise molecular mass of the intended compound; Hadwiger et al. (2012) is an example of an LC-HRMS impurity method applied to a marketplace drug.

Can two independent labs report different purity numbers for the same vial, and if so, why?

Yes. Different laboratories may use different HPLC columns, solvent gradients, mobile phase pH levels, temperatures, or detection settings. A method with higher chromatographic resolving power can separate trace impurities that a faster, lower-resolution method misses, leading to slight variations in the calculated area percentage.

Does a high purity percentage on its own tell you the vial contains the compound the label claims?

No. An HPLC purity percentage only reports that the detected material was chromatographically uniform under that run's conditions. It does not confirm molecular identity on its own. Mass spectrometry or orthogonal reference standard comparison is required to confirm that the observed material has the correct molecular weight and structure.

How Peptide Purity Is Actually Measured: HPLC, Mass Spectrometry, and What the Numbers Mean

When evaluating research peptides, a printed purity figure—such as 98% or 99%—is frequently presented as a definitive quality stamp. In analytical chemistry, however, that number is not an intrinsic property stamped onto a molecule. Rather, it represents the specific output of an analytical testing method with its own technical constraints. Understanding how analytical tools like High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) evaluate laboratory samples allows buyers to interpret laboratory reports accurately and understand why testing discrepancies occur.

What HPLC Measures (and What It Misses)

High-Performance Liquid Chromatography (HPLC), particularly reversed-phase HPLC, is the primary technique used to quantify peptide purity. In an HPLC run, a sample is dissolved in a solvent and pumped under high pressure through a column packed with a stationary phase material. Different chemical species travel through the column at different rates based on their molecular interactions with the column material and mobile solvent phase. As molecules exit the column, an optical detector (typically ultraviolet absorbance at 214 nm or 220 nm, corresponding to peptide bonds) records the signals as peaks on a chromatogram.

Purity by HPLC is calculated as an area-under-the-curve percentage: the area of the primary target peak divided by the total area of all detected peaks. Farid et al. (1989) describe reversed-phase and size-exclusion HPLC assays used to control the identity, purity and content of recombinant human insulin and growth hormone, an example of how routine the method is for peptide and protein drugs. However, this measurement carries intrinsic limitations. An optical detector only measures components that absorb light at the chosen wavelength and elute from the column during the run. Counterions (such as acetate or trifluoroacetate), residual water, residual synthesis solvents, inorganic salts, and impurities that bind permanently to the column do not appear as peaks. Consequently, an HPLC reading reflects relative chromatographic area purity among detectable ultraviolet-absorbing species, not the absolute net weight of the peptide in the vial.

Why Mass Spectrometry Is Necessary for Identity

HPLC alone cannot confirm what a molecule actually is; it only measures how long a compound takes to pass through a column under specific conditions. A contaminant that happens to elute at the same time as the target compound can hide beneath the main peak, yielding an artificially elevated purity reading.

To establish identity, analytical chemists pair liquid chromatography with mass spectrometry (LC-MS). While chromatography separates molecules over time, mass spectrometry ionizes the molecules and measures their mass-to-charge ratio (m/z), yielding a precise molecular weight. Hadwiger et al. (2012) show the approach on a marketplace drug: a U.S. government laboratory paired high-resolution mass spectrometry with diode-array detection to characterize impurities in marketplace vancomycin products (a glycopeptide antibiotic), then linked the impurity profiles to a potency assay. By combining retention time data from HPLC with molecular mass verification from MS, laboratories can verify both that the predominant molecule matches the expected molecular weight and that optical purity calculations are grounded in confirmed structural identity.

Why Two Laboratories Can Report Different Numbers

It is common for independent analytical laboratories to report slightly different purity percentages for aliquots taken from the same manufacturing batch. These differences do not necessarily indicate testing error; instead, they reflect differences in analytical parameters.

Chromatographic resolution depends on several operational variables: column chemistry (such as C18 versus C4 or phenyl phases), particle size, column temperature, mobile phase gradient slope, pH, flow rate, and detection wavelength. A laboratory using a steep solvent gradient or a shorter column may fail to resolve a minor deletion peptide from the main target peak, recording it as a single combined peak and yielding a higher purity value. Conversely, a laboratory applying an extended gradient on a high-efficiency column with high-resolution MS capabilities may resolve those minor variants into distinct peaks, resulting in a slightly lower calculated purity percentage for the primary peak.

Evaluating Verifiable Quality in Laboratory Compounds

Understanding analytical metrics helps researchers separate marketing claims from concrete documentation. Relying on a single printed purity claim on a sales page offers limited insight without access to the underlying testing methodology.

A verifiable research source substantiates its catalog with batch-specific documentation from an independent analytical laboratory. Robust analytical standards include:

• An unredacted High-Performance Liquid Chromatogram (HPLC) showing peak integration, baseline separation, and running conditions.

• A High-Resolution Mass Spectrometry (HR-MS) spectrum confirming that the observed molecular weight corresponds to the theoretical mass.

• Batch-specific testing for residual bacterial endotoxins and microbiological contaminants.

Evaluating the full testing documentation rather than a standalone percentage ensures that identity and analytical limits are transparently assessed.

Common questions

What does 'purity' mean when it's printed on a peptide vial's label?: When printed on a research peptide vial, 'purity' typically refers to relative chromatographic purity determined by HPLC. It indicates the percentage of detectable, light-absorbing material that eluted at the expected retention time relative to all detected peaks. It does not mean the vial contains 100% active compound by weight, as non-absorbing components like moisture, counterions, and buffer salts are not accounted for in standard HPLC area percentages.
What is HPLC actually measuring when it reports a purity percentage?: HPLC measures the relative optical absorbance (commonly at 214 nm or 220 nm) of compounds as they separate through a stationary column over time. The purity percentage is calculated by dividing the area under the primary compound's peak by the sum of all integrated peak areas on the chromatogram.
How is mass spectrometry different from HPLC, and why do labs often run both?: HPLC separates compounds by their chemical affinity and retention time on a column, whereas mass spectrometry measures the exact mass-to-charge ratio of ionized molecules to determine their molecular weight. Running both (LC-MS) allows a laboratory to separate impurities and verify that the target peak matches the precise molecular mass of the intended compound; Hadwiger et al. (2012) is an example of an LC-HRMS impurity method applied to a marketplace drug.
Can two independent labs report different purity numbers for the same vial, and if so, why?: Yes. Different laboratories may use different HPLC columns, solvent gradients, mobile phase pH levels, temperatures, or detection settings. A method with higher chromatographic resolving power can separate trace impurities that a faster, lower-resolution method misses, leading to slight variations in the calculated area percentage.
Does a high purity percentage on its own tell you the vial contains the compound the label claims?: No. An HPLC purity percentage only reports that the detected material was chromatographically uniform under that run's conditions. It does not confirm molecular identity on its own. Mass spectrometry or orthogonal reference standard comparison is required to confirm that the observed material has the correct molecular weight and structure.